Cancer-associated adipocyte promote progression and immunosuppression in triple-negative breast cancer
Frontiers in Oncology · 16.04.2026 · 16
DOI: 10.3389/fonc.2026.1797152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 16.04.2026. Verfasst von Xichao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Laboratory, Shandong Second Medical University, Weifang, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is characterized by highmetastatic potential and a lack of effective targeted therapies. Within the tumor microenvironment (TME) of TNBC, adipocyte can undergo transformation into cancer-associated adipocytes (CAA) through interactions with cancer cells; however, the specific role in the progress of TNBC is still not well described. This study aimed to investigate the impact of CAA on the malignant behavior of TNBC and its underlying mechanisms. CAA model was successfully established by co-culturing 3T3-L1-induced adipocytes with 4T1 cells, which exhibited characteristic features such as reduced lipid accumulation. Functional assays demonstrated that co-culture with CAA significantly enhanced the migration and invasion capabilities of 4T1 cells. In vivo experiments showed that co-injection of CAA with tumor cells accelerated primary tumor growth and promoted lung metastasis in mice. Mechanistic analysis revealed that in tumor tissues coexisting with CAA, E-cadherin expression was downregulated, accompanied by increased Ki67 expression and activation of the PI3K/AKT signaling pathway. Furthermore, CAA induces an immunosuppressive TME, characterized by elevated PD-L1 expression and reduced CD8 + T cell infiltration. In conclusion, this study demonstrates that CAA promotes TNBC progression by activating epithelial-mesenchymal transition (EMT) and the PI3K/AKT pathway, as well as remodeling an immunosuppressive microenvironment, providing experimental insight into tumor-adipocyte interactions and identifying potential therapeutic targets.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medical Laboratory, Shandong Second Medical University, Weifang, China.
- Department of Clinical Laboratory, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
- School of Rehabilitation Science and Engineering, University of Health and Rehabilitation Sciences, Qingdao, China.
- Emergency Center, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
Zitieren
APA
Zhang, X., Zhong, S., Liu, S., Mu, X., Chen, G., & Chen, W. (2026). Cancer-associated adipocyte promote progression and immunosuppression in triple-negative breast cancer. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1797152
Vancouver
Zhang X, Zhong S, Liu S, Mu X, Chen G, Chen W. Cancer-associated adipocyte promote progression and immunosuppression in triple-negative breast cancer. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1797152
BibTeX
@article{Zhang2026,
author = {Zhang, Xichao and Zhong, Shenjie and Liu, Shan and Mu, Xiaofeng and Chen, Gang and Chen, Wen},
title = {Cancer-associated adipocyte promote progression and immunosuppression in triple-negative breast cancer},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1797152}
}
EUVIMED